Prof. Roberto Iacovelli studied medicine at the “Sapienza” University of Rome, Italy. At the same university, he specialized in medical oncology and obtained his Ph.D. in molecular medicine and human pathology with a focus on genitourinary cancers. He had international experience as a fellow at the Institute Gustave Roussy in France and he served as an oncologist in main referral oncological centres in Italy. Currently, he is an associate professor of Medical Oncology at the Catholic University of the Sacred Heart, Rome, and serves as oncologist at the Fondazione Policlinico Gemelli IRCCS in Rome, Italy, which is one of the major national hospitals, with more than 1500 beds and an active Comprehensive Cancer Centre. His research activities have a focus on metastatic renal cell carcinoma and prostate and bladder cancer. His major interest is in the predictive/prognostic factors in GU cancers, as well as the sequence of therapy in renal cancer and the new combination of therapies in GU tumours. He has participated as a PI or sub-investigator in many sponsored and academic clinical trials and has published more than 150 papers in international peer-reviewed journals and several abstracts at international conferences on these topics. He has received many national and international awards, such as the ASCO Cancer Foundation Merit Award in 2011 and the best poster award at the ESMO congress in 2012 and is currently a member of the Italian Guidelines for Kidney and Prostate tumour.